Stop TB Partnership 405d ago

Tuberculosis (TB) continues to be the world’s deadliest infectious disease, claiming an estimated 1.3 million lives annually with over 10 million people developing the disease each year, according to the latest WHO Global TB Report. Despite significant strides in TB control over decades, the global response is faced with several challenges, with incidence and mortality rates declining by only 2% annually—far below the more than 10% annual reduction needed to meet the 2030 End TB targets. High-burden countries face escalating challenges: annually over 2 million people with TB are not diagnosed and treated, and well over half of the estimated 400,000 new drug-resistant TB cases remain undiagnosed and untreated; funding gaps persist at $15 billion per year; and the adoption and scale up of several exciting new life-saving and game changing innovations remains slow. With just five years remaining to achieve the United Nations’ Sustainable Development Goals (SDGs) and the End TB Strategy targets for 2030, this meeting represents a pivotal moment to accelerate progress through bold political leadership, transformative innovation, and sustainable financing.